Obesity Linked to Rising Hypertension and Diabetes Risks, Study Finds

A recent study published in BMC Public Health highlights that obesity is closely associated with a range of metabolic comorbidities. Among adults with obesity, the prevalence of hypertension climbs from 29% in ages 18‑39 to 66.2% in ages 40‑64 and reaches 89.4% in those over 65. Dyslipidemia follows a similar pattern, affecting 28.1%, 65.4% and 88% of the same age groups respectively.

Dr. Júlia Chagas explains that excess visceral fat is metabolically active, producing inflammatory substances that impair insulin signaling: “This fat is not just an energy depot; it is metabolically active and produces inflammatory substances that interfere with insulin action in cells.” The resulting insulin resistance can precede type 2 diabetes by years, eventually leading to persistent high blood sugar. Chronic low‑grade inflammation from visceral adipose tissue also raises the risk of cardiovascular disease, liver steatosis, and neurodegenerative disorders.

The findings underscore that obesity is a systemic health condition, not merely an aesthetic concern, requiring individualized management of its associated comorbidities.